Evidence map›Paper›PMID 27069113›Full record

ArticleThe Journal of experimental medicine2016

B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6.

Shaun W Jackson, Holly M Jacobs, Tanvi Arkatkar, Elizabeth M Dam, Nicole E Scharping, Nikita S Kolhatkar, Baidong Hou, Jane H Buckner, David J Rawlings

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 211 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Immune Modulatory Effects of PD-1/PD-L1 in Myasthenia Gravis: Insights From Peripheral Blood Mononuclear Cell Analysis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Shaun W JacksonSeattle Children's Research Institute, Seattle, WA 98105 Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195.
Holly M JacobsSeattle Children's Research Institute, Seattle, WA 98105.
Tanvi ArkatkarSeattle Children's Research Institute, Seattle, WA 98105.
Elizabeth M DamBenaroya Research Institute, Seattle, WA 98101.
Nicole E ScharpingSeattle Children's Research Institute, Seattle, WA 98105.
Nikita S KolhatkarSeattle Children's Research Institute, Seattle, WA 98105 Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195.
Baidong HouInstitute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Jane H BucknerBenaroya Research Institute, Seattle, WA 98101.
David J RawlingsSeattle Children's Research Institute, Seattle, WA 98105 Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195 Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195 drawling@uw.edu.
University of Washington · USBenaroya Research InstituteChinese Academy of Sciences · CN

Funding

RESEARCH TRAINING IN RHEUMATOLOGYT32AR007108 · NIAMS · UNIVERSITY OF WASHINGTON · PI Shaun Jackson, Tomas M Mustelin · 1986 to 2026
$6.6M
Defining the functional impact of T1D genes in mouse and man: a unified strategyDP3DK097672 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI BUCKNER, JANE HOYT · 2012 to 2013
$4.4M
Lentiviral Gene Therapy for Wiskott-Aldrich SyndromeR01AI071163 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2008 to 2012
$3.5M
Lentiviral Gene Therapy of X-Linked AgammaglobulinemiaR01AI084457 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2012 to 2015
$2.5M
Lentiviral Gene Therapy of X-linked AgammaglobulinemiaR01HL075453 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2004 to 2008
$1.9M
B cell-intrinsic cytokine regulation and B cell-targeted therapies in murine lupuK08AI112993 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI JACKSON, SHAUN WILLIAM · 2014 to 2018
$910k
NHLBI NIH HHS R01 HL075453NIAID NIH HHS K08 AI112993NIAID NIH HHS R01 AI071163NIAID NIH HHS R01 AI084457NIAMS NIH HHS T32 AR007108NIDDK NIH HHS DP3 DK097672
6 · The paper itself

Abstract

Dysregulated germinal center (GC) responses are implicated in the pathogenesis of human autoimmune diseases, including systemic lupus erythematosus (SLE). Although both type 1 and type 2 interferons (IFNs) are involved in lupus pathogenesis, their respective impacts on the establishment of autoimmune GCs has not been addressed. In this study, using a chimeric model of B cell-driven autoimmunity, we demonstrate that B cell type 1 IFN receptor signals accelerate, but are not required for, lupus development. In contrast, B cells functioning as antigen-presenting cells initiate CD4(+) T cell activation and IFN-γ production, and strikingly, B cell-intrinsic deletion of the IFN-γ receptor (IFN-γR) abrogates autoimmune GCs, class-switched autoantibodies (auto-Abs), and systemic autoimmunity. Mechanistically, although IFN-γR signals increase B cell T-bet expression, B cell-intrinsic deletion of T-bet exerts an isolated impact on class-switch recombination to pathogenic auto-Ab subclasses without impacting GC development. Rather, in both mouse and human B cells, IFN-γ synergized with B cell receptor, toll-like receptor, and/or CD40 activation signals to promote cell-intrinsic expression of the GC master transcription factor, B cell lymphoma 6 protein. Our combined findings identify a novel B cell-intrinsic mechanism whereby IFN signals promote lupus pathogenesis, implicating this pathway as a potential therapeutic target in SLE.

Indexed as

AnimalsAutoantibodiesB-LymphocytesGerminal CenterInterferon-gammaInterferon gamma ReceptorLupus Erythematosus, SystemicMaleMiceMice, KnockoutProto-Oncogene Proteins c-bcl-6Receptors, InterferonSignal TransductionToll-Like ReceptorsAutoantibodiesBCL6 protein, humanBcl6 protein, mouseIFNG protein, mouseInterferon-gammaInterferon gamma ReceptorProto-Oncogene Proteins c-bcl-6Receptors, InterferonToll-Like Receptors

Identifiers

PMID27069113
PMCPMC4854732
OpenAlexW2324116468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.